The development of hepatic steatosis has been observed in mice with liver-specific deletion of the GH receptor (GHR) (14, 15), liver-specific JAK2-deficient mice (16), or STAT5-deficient mice (17). This evidence concerns the gene GHR and fatty liver disease.